PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01585649
Recruitment Status : Completed
First Posted : April 26, 2012
Last Update Posted : May 18, 2016
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Merckle GmbH )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2014
  Actual Study Completion Date : April 2015